198 related articles for article (PubMed ID: 20082653)
1. Risk factors for implantable defibrillator lead fracture in a recalled and a nonrecalled lead.
Morrison TB; Rea RF; Hodge DO; Crusan D; Koestler C; Asirvatham SJ; Bradley D; Shen WK; Munger TM; Hammill SC; Friedman PA
J Cardiovasc Electrophysiol; 2010 Jun; 21(6):671-7. PubMed ID: 20082653
[TBL] [Abstract][Full Text] [Related]
2. Impact of implanted recalled sprint Fidelis lead on patient mortality.
Morrison TB; Friedman PA; Kallinen LM; Hodge DO; Crusan D; Kumar K; Hayes DL; Rea RF; Hauser RG
J Am Coll Cardiol; 2011 Jul; 58(3):278-83. PubMed ID: 21737019
[TBL] [Abstract][Full Text] [Related]
3. Time-dependent risk of Fidelis lead failure.
Faulknier BA; Traub DM; Aktas MK; Aguila A; Rosero S; Daubert JP; Hall B; Shah A; Taylor S; McNitt S; Moss AJ; Zareba W; Huang DT
Am J Cardiol; 2010 Jan; 105(1):95-9. PubMed ID: 20102898
[TBL] [Abstract][Full Text] [Related]
4. Risk of Sprint Fidelis defibrillator lead failure is highly dependent on age.
Girerd N; Nonin E; Pinot J; Morel E; Flys C; Scridon A; Chevalier P
Arch Cardiovasc Dis; 2011; 104(6-7):388-95. PubMed ID: 21798471
[TBL] [Abstract][Full Text] [Related]
5. Predictors of fracture risk of a small caliber implantable cardioverter defibrillator lead.
Ha AC; Vezi BZ; Keren A; Alanazi H; Gollob MH; Green MS; Lemery R; Nery PB; Posan E; Birnie DH
Pacing Clin Electrophysiol; 2010 Apr; 33(4):437-43. PubMed ID: 19954500
[TBL] [Abstract][Full Text] [Related]
6. Longevity of Sprint Fidelis implantable cardioverter-defibrillator leads and risk factors for failure: implications for patient management.
Hauser RG; Maisel WH; Friedman PA; Kallinen LM; Mugglin AS; Kumar K; Hodge DO; Morrison TB; Hayes DL
Circulation; 2011 Feb; 123(4):358-63. PubMed ID: 21242478
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes in patients with implantable cardioverter defibrillators and Sprint Fidelis leads.
Verlato R; Facchin D; Catanzariti D; Molon G; Zanotto G; Morani G; Brieda M; Zanon F; Delise P; Leoni L; Comisso J; Campo C
Heart; 2013 Jun; 99(11):799-804. PubMed ID: 23434626
[TBL] [Abstract][Full Text] [Related]
8. Sensing failure associated with the Medtronic Sprint Fidelis defibrillator lead.
Kenigsberg DN; Mirchandani S; Dover AN; Kowalski M; Wood MA; Shepard RK; Kalahasty G; Stein KM; Markowitz SM; Iwai S; Shah BK; Lerman BB; Mittal S; Ellenbogen KA
J Cardiovasc Electrophysiol; 2008 Mar; 19(3):270-4. PubMed ID: 18179527
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal follow-up of implantable cardioverter defibrillator leads.
Liu J; Brumberg G; Rattan R; Patel D; Adelstein E; Jain S; Saba S
Am J Cardiol; 2014 Jan; 113(1):103-6. PubMed ID: 24176060
[TBL] [Abstract][Full Text] [Related]
10. Update on small-diameter implantable cardioverter-defibrillator leads performance.
van Rees JB; van Welsenes GH; Borleffs CJ; Thijssen J; van der Velde ET; van der Wall EE; van Erven L; Schalij MJ
Pacing Clin Electrophysiol; 2012 Jun; 35(6):652-8. PubMed ID: 22352338
[TBL] [Abstract][Full Text] [Related]
11. Trends in Fidelis lead survival: transition from an exponential to linear pattern of lead failure over time.
Cheung JW; Tobin-Hess A; Patel A; Slotwiner DJ; Goldner BG
Circ Arrhythm Electrophysiol; 2012 Oct; 5(5):906-12. PubMed ID: 22923271
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Sprint Fidelis and Riata defibrillator lead failure rates.
Fazal IA; Shepherd EJ; Tynan M; Plummer CJ; McComb JM
Int J Cardiol; 2013 Sep; 168(2):848-52. PubMed ID: 23138013
[TBL] [Abstract][Full Text] [Related]
13. Lead electrical parameters may not predict integrity of the Sprint Fidelis ICD lead.
Maytin M; Epstein LM
Heart Rhythm; 2012 Sep; 9(9):1446-51. PubMed ID: 22537883
[TBL] [Abstract][Full Text] [Related]
14. Psychological effects of implantable cardioverter-defibrillator leads under advisory.
Heatherly SJ; Simmons T; Fitzgerald DM; Mitchell M
Pacing Clin Electrophysiol; 2011 Jun; 34(6):694-9. PubMed ID: 21410721
[TBL] [Abstract][Full Text] [Related]
15. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
[TBL] [Abstract][Full Text] [Related]
16. Multi-institutional study of implantable defibrillator lead performance in children and young adults: results of the Pediatric Lead Extractability and Survival Evaluation (PLEASE) study.
Atallah J; Erickson CC; Cecchin F; Dubin AM; Law IH; Cohen MI; Lapage MJ; Cannon BC; Chun TU; Freedenberg V; Gierdalski M; Berul CI;
Circulation; 2013 Jun; 127(24):2393-402. PubMed ID: 23694966
[TBL] [Abstract][Full Text] [Related]
17. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years.
Kleemann T; Becker T; Doenges K; Vater M; Senges J; Schneider S; Saggau W; Weisse U; Seidl K
Circulation; 2007 May; 115(19):2474-80. PubMed ID: 17470696
[TBL] [Abstract][Full Text] [Related]
18. Failure of implantable cardioverter-defibrillator leads: a matter of lead size?
Rordorf R; Poggio L; Savastano S; Vicentini A; Petracci B; Chieffo E; Klersy C; Landolina M
Heart Rhythm; 2013 Feb; 10(2):184-90. PubMed ID: 23063430
[TBL] [Abstract][Full Text] [Related]
19. Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure.
Hauser RG; Hayes DL
Heart Rhythm; 2009 May; 6(5):605-10. PubMed ID: 19285920
[TBL] [Abstract][Full Text] [Related]
20. Inappropriate implantable cardioverter defibrillator shocks in fractured Sprint Fidelis leads associated with 'appropriate' interrogation.
Farwell D; Redpath C; Birnie D; Gollob M; Lemery R; Posan E; Green M
Europace; 2008 Jun; 10(6):726-8. PubMed ID: 18456645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
